CJC-1295 and Ipamorelin

Co-administered

A growth-hormone secretagogue pairing. One murine study has given both together; the human evidence is not there yet.

How the two mechanisms relate

Synergy. CJC-1295 is a GHRH analogue and Ipamorelin a ghrelin-receptor agonist, two different receptors on the growth-hormone axis, and the two were co-administered in the cited work.

This reading describes mechanism and is editorial. The grade above is the published record.

The compounds

CJC-1295

A long-acting GHRH analogue studied for growth-hormone release. Two early human trials measured hormone levels; no human study here reports a functional outcome.

Full profile, dosing and safety →

Ipamorelin

A selective growth-hormone secretagogue and ghrelin-receptor agonist. Outcome data are animal, and two completed human trials report status and title only.

Full profile, dosing and safety →

Check these in the interaction tool →